Romano-Keeler et al., 2014 - Google Patents
Great expectorations: the potential of salivary 'omic'approaches in neonatal intensive careRomano-Keeler et al., 2014
View PDF- Document ID
- 8339318658161131806
- Author
- Romano-Keeler J
- Wynn J
- Maron J
- Publication year
- Publication venue
- Journal of Perinatology
External Links
Snippet
Among those that require critical care, preterm neonates have the greatest limitations on available blood or body fluids for clinical or research-based assessments. Recent technological advancements have improved our ability to detect genetic, proteomic and …
- 206010036790 Productive cough 0 title description 4
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Boroumand et al. | Saliva, a bodily fluid with recognized and potential diagnostic applications | |
Martin et al. | Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury | |
Ohyama et al. | Saliva as a potential tool for diagnosis of dry mouth including Sjögren's syndrome | |
Romano-Keeler et al. | Great expectorations: the potential of salivary ‘omic’approaches in neonatal intensive care | |
Hassaneen et al. | Salivary diagnostics in pediatrics: applicability, translatability, and limitations | |
Fung et al. | Intrauterine growth restriction alters mouse intestinal architecture during development | |
Borghi et al. | Antenatal microbial colonization of mammalian gut | |
Dikow et al. | The phenotypic spectrum of duplication 5q35. 2–q35. 3 encompassing NSD1: is it really a reversed Sotos syndrome? | |
Ries et al. | Importance of the PD-1/PD-L1 axis for malignant transformation and risk assessment of oral leukoplakia | |
Starzyńska et al. | Association between maternal periodontitis and development of systematic diseases in offspring | |
Nelson et al. | Shwachman-diamond syndrome | |
Mazzitelli et al. | Liquid biopsy in the management of breast cancer patients: where are we now and where are we going | |
Nakamura et al. | Initial pulmonary respiration causes massive diaphragm damage and hyper-CKemia in Duchenne muscular dystrophy dog | |
Guida et al. | Genome-Wide DNA methylation analysis of a cohort of 41 patients affected by oculo-auriculo-vertebral spectrum (OAVS) | |
Wu et al. | Novel mutations detection with next-generation sequencing and its association with clinical outcome in unilateral primary aldosteronism | |
Semlali et al. | Expression and polymorphism of TSLP/TSLP receptors as potential diagnostic markers of colorectal cancer progression | |
Zaragoza-Huesca et al. | Identification of thrombosis-related genes in patients with advanced gastric cancer: data from AGAMENON-SEOM registry | |
Danesino et al. | Hereditary hemorrhagic telangiectasia in pediatric age: focus on genetics and diagnosis | |
Xu et al. | Maternal antibiotic exposure enhances ILC2 activation in neonates via downregulation of IFN1 signaling | |
Mauri et al. | Early-onset cancers: Biological bases and clinical implications | |
Pallante et al. | Liquid biopsy is a promising tool for genetic testing in idiopathic pulmonary fibrosis | |
Spiliopoulou et al. | Promising and minimally invasive biomarkers: targeting melanoma | |
Pechmann et al. | Increased von Willebrand factor parameters in children with febrile seizures | |
Nagata et al. | Association of ALPL variants with serum alkaline phosphatase and bone traits in the general Japanese population: The Nagahama Study | |
Alqahtani et al. | Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing |